Banadaki, Mohammad Dehghan
Rummel, Nicole G.
Backus, Spencer
Butterfield, David Allan
St. Clair, Daret K.
Campbell, James M.
Zhong, Weixiong
Mayer, Kristy
Berry, Scott M.
Chaiswing, Luksana
Funding for this research was provided by:
Center for Disease Control and Prevention (BAA 75D301-20-R-68024)
Directorate for Biological Sciences (2154934)
Markey Cancer Center, University of Kentucky (P30 CA177558)
National Institute of Health (1U01DA053903-01)
National Institute of Health (P20 GM148326)
National Institute of Health (P30 ES026529)
National Institute of Health (R01 CA217934)
National Institute of Health (R01 CA251663)
Article History
Received: 17 May 2024
Revised: 18 August 2024
Accepted: 21 August 2024
First Online: 7 September 2024
Change Date: 2 October 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00216-024-05568-3
Declarations
:
: The authors declare the following competing financial interest: Scott Berry has an ownership interest in Salus Discovery, LLC, which has licensed the ESP technology described in the text. All other authors declare no conflict of interest.